ZTS Notícias Sobre o Forex
Zoetis Boosts FY24 Outlook As Q2 Results Top Estimates
While reporting financial results for the second quarter on Tuesday, animal health company Zoetis, Inc. (ZTS) raised its earnings, adjusted earnings and revenue guidance for the full year 2024.
RTTNews
|
81 dias atrás
EU Opens Formal Antitrust Investigation Against Zoetis For Potential Anticompetitive Behavior
The European Commission said Tuesday it has opened a formal antitrust investigation to assess whether animal health company Zoetis, Inc. (ZTS) may have breached EU competition rules by preventing the market launch of a competing novel biologic medicine used to treat chronic pain in dogs.
RTTNews
|
214 dias atrás
Zoetis Maintains FY23 Outlook; Q1 Adj. EPS Tops Estimates
While reporting financial results for the first quarter on Thursday, animal health company Zoetis Inc. (ZTS) maintained its earnings, adjusted earnings and revenue guidance for the full year 2023.
RTTNews
|
541 dias atrás
Zoetis Again Slashes FY22 Outlook As Q3 Results Miss Estimates; Stock Down 11%
While reporting financial results for the third quarter on Thursday, animal health company Zoetis Inc. (ZTS) again slashed its earnings, adjusted earnings and revenue guidance for the full year 2022, to reflect lower than expected sales due to continued supply constraints, veterinary workforce challenges, as well as the negative impact of recent changes to foreign exchange rates.
RTTNews
|
723 dias atrás
Zoetis Guides Trims FY22 Outlook; Q2 Profit Down 3%
While reporting financial results for the second quarter on Thursday, animal health company Zoetis Inc. (ZTS) trimmed its earnings and revenue guidance for the full year 2022.
RTTNews
|
814 dias atrás
